Delivery Order SPE2DB20D3104-SPE2DB24FV7G1

Award Date 6/3/24
Potential Completion Date 6/4/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $34,943.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract with a Firm Fixed Price pricing type, with a completion date of February 6, 2025. The contract covers the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen holds a significant...
This federal contract award is a delivery order valued at $16,240.08 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award is for JARDIANCE 25 MG TABLET 90S, a medical product. The contract has an ultimate completion date of February 27, 2025 and is a firm fixed price contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,386.87, is a delivery order for the medication JARDIANCE 10 MG TABLET 90S. The contract has an ultimate completion date of May 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,067.16 firm fixed price delivery order is for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of April 8, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $58,676.27 with a completion date of December 11, 2024. The contract was awarded by the Defense Logistics Agency (DLA) and involves the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Jardiance 25 mg tablets. The $12,835.82 firm fixed-price delivery order contract has an ultimate completion date of February 2, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award is a delivery order valued at $36,849.78 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product JARDIANCE 25 MG TABLET 90S and has a completion date of January 3, 2025. The contract has a firm fixed price pricing type and is not associated with any set-aside designation. Amerisourcebergen holds a significant...
This federal contract award is a delivery order valued at $31,670.10 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a period of performance through June 13, 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,067.49, is a delivery order for the product "JARDIANCE 25 MG TABLET 90S" with a completion date of December 18, 2023. The contract is a firm fixed-price type with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) with a ceiling value of $6,030.78. The award is for the delivery of JARDIANCE 10 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of February 12, 2025 and is a firm fixed-price delivery order. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB24FV7G1
    Delivery Order

This federal contract award, valued at $1,359.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of June 4, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen, as the prime contractor, is responsible for the delivery of the pharmaceutical product to the DLA.

Generated 5/16/25, 11:55 AM